The Benefits of Restorative Programming for Skilled Nursing Facilities 
AGTC to Participate in the Stifel 2021 Virtual Healthcare Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Merus to Participate in a Fireside Chat at the Jefferies London Healthcare Conference (Virtual)
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...
X4 Pharmaceuticals to Participate in Stifel’s Virtual Healthcare Conference
BOSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Company to Host Conference Call Today at 9 a.m. EST CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE...
Mersana Therapeutics to Present at the Upcoming Stifel 2021 Virtual Healthcare Conference
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients into Spain
Nes Ziona, Israel, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
Brain Scientific Announces the Appointment of Independent Board Members
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a leader in the Medical...
Hepion Pharmaceuticals Announces Poster Details for the Upcoming AASLD The Liver Meeting® 2021
EDISON, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
Portage Biotech Hosting Key Opinion Leader Webinar on How iNKT Agonists Could Improve Immuno-Oncology Treatment
Thursday, November 18th @ 10amETWESTPORT, Conn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the...
Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company Update
Significant progress on several key clinical and corporate initiatives with the portfolio during the third quarter, including DARE-BV1 NDA acceptance...
Anti-Cancer Mechanism of Hepion Pharmaceuticals’ CRV431 Highlighted in Scripps Research Institute Poster at AASLD, The Liver Meeting® 2021
EDISON, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
SCYNEXIS Reports Third Quarter 2021 Financial Results and Provides Corporate Update
BREXAFEMME® (ibrexafungerp tablets) net sales of $0.5 million generated since August, with IQVIA reporting 1,006 prescriptions in partial Q3; momentum...
Arbutus to Participate at Jefferies London Healthcare Conference
WARMINSTER, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Chalice Brands Ltd. to Report Third Quarter 2021 Financial and Operating Results
PORTLAND, Ore., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a...
VYNE Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Lead BET Inhibitor Candidate, VYN201, Demonstrates Potent Anti-Inflammatory Effect in Preclinical Studies VYN201 Expected to Enter Clinic in 2022 Phase...
LivaNova to Present at the 2021 Stifel and Jefferies Healthcare Conferences
LONDON--(BUSINESS WIRE)--#cardiovascular--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present...
Seven Healthcare Industry “High Reliability Organization Champions” Recognized by Patient Safety Movement Foundation
HRO Champion Designation Underscores Ongoing Commitment to Data Transparency and Becoming a Safe and Reliable Healthcare Organization IRVINE, Calif.--(BUSINESS WIRE)--#HROChampion--Medical...
Surescripts Announces Planned CEO Transition
Tom Skelton to Step Down in December 2022 After More Than Seven Years at Helm; Company Initiates Search for Successor...
Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
MADISON, Wis.--(BUSINESS WIRE)--#biofilm--Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S....
CureVac Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate CV8102 Showing Systemic Immune Response
∙ Immune profiling of clinical trial participants in Phase 1 dose-escalation study shows immune response in both injected and non-injected...